Skip to Content

Liotrix (Levothyroxine/Liothyronine T4/T3)

Last Updated: February 11, 2019
Status: Discontinued

Products Affected - Description
    • Thyrolar oral tablet, Actavis, 12.5 mcg/3.1 mcg 100 count, NDC 00456-0040-01
    • Thyrolar oral tablet, Actavis, 25 mcg/6.25 mcg 100 count, NDC 00456-0045-01
    • Thyrolar oral tablet, Actavis, 150 mcg/37.5 mcg 100 count, NDC 00456-0060-01
    • Thyrolar oral tablet, Actavis, 100 mcg/25 mcg 100 count, NDC 00456-0055-01
    • Thyrolar oral tablet, Actavis, 50 mcg/12.5 mcg 100 count, NDC 00456-0050-01
Reason for the Shortage
    • Thyrolar tablets from Actavis (formerly Forest) were on shortage due to manufacturing changes.
Available Products
    • No presentations are available.

Estimated Resupply Dates

    • Actavis (formerly Forest) discontinued all Thyrolar presentations in September 2018.

Updated

Updated February 11, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 28, 2005 by Jane Chandramouli, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.